What is the relationship between the researcher and the pharmaceutical company?

Drug researchers often look to pharmaceutical companies for grants and pharmaceutical companies often look to researches for studies that will make their brand look favourable. Is this a good relationship?

Are pharmaceutical companies always reliable with their intentions? For example, do they sometimes only publish favourable data? 

What do they normally look for when approving studies for grants?

Why do they like to influence or entangle researchers?

Interesting read: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1126053/

More Charlotte Worrall's questions See All
Similar questions and discussions